← All story threadsSTORY THREAD

Ethics questions over US hormone therapy policy.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 29, 2026
    OFFICIAL BACKED HRT SHIFT WHILE HOLDING COMPANY STOCKFinancial disclosure records

    Report: US health official backed hormone therapy shift while owning stock

    ProPublica reports that ARPA-H director Alicia Jackson praised the end of strong warnings on menopause hormone therapy while holding stock in Evernow, the menopause care company she founded.